A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model

Tissue Engineering - Part A

Volumn 18, Issue 9-10, 2012, Pages 1079-1086

  Behr, Björn ^a,b   Sorkin, Michael ^a   Lehnhardt, Marcus ^b   Renda, Andrea ^c   Longaker, Michael T ^a   Quarto, Natalina ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEFECTS; PEPTIDES; TISSUE ENGINEERING;

BONE HEALING; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; CALVARIAL DEFECTS; COMPARATIVE ANALYSIS; FIBROBLAST GROWTH FACTOR-2; GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; IN-VIVO; OSTEOGENIC EFFECTS; OSTEOPROGENITOR CELLS; THERAPEUTIC USE; TRANSLATIONAL MEDICINE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BONE;

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN A;

ANIMAL; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; INJURY; MOUSE; SKULL; WOUND HEALING;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; MICE; OSTEOGENESIS; SKULL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84860498840     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0537     Document Type: Article

References (47)

1. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
2. Jones, A.L., Bucholz, R.W., Bosse, M.J., Mirza, S.K., Lyon, T.R., Webb, L.X., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88, 1431, 2006.
3. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A, 2123, 2002.
4. Aro, H.T., Govender, S., Patel, A.D., Hernigou, P., Perera de Gregorio, A., Popescu, G.I., et al. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am Vol 93, 801, 2011.
5. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Nat Acad Sci USA 99, 9656, 2002.
6. Chen, W.J., Jingushi, S., Aoyama, I., Anzai, J., Hirata, G., Tamura, M., et al. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab 22, 303, 2004.
7. Schmidmaier, G., Wildemann, B., Gabelein, T., Heeger, J., Kandziora, F., Haas, N.P., et al. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand 74, 604, 2003.
8. Hollinger, J.O., Onikepe, A.O., MacKrell, J., Einhorn, T., Bradica, G., Lynch, S., et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable betatricalcium phosphate/collagen matrix. J Orthop Res 26, 83, 2008.
9. Bernstein, A., Mayr, H.O., and Hube, R. Can bone healing in distraction osteogenesis be accelerated by local application of IGF-1 and TGF-beta1? J Biomed Mater Res B Appl Biomater 92, 215, 2010.
10. Chang, P.C., Seol, Y.J., Cirelli, J.A., Pellegrini, G., Jin, Q., Franco, L.M., et al. PDGF-B gene therapy accelerates bone engineering and oral implant osseointegration. Gene Ther 17, 95, 2010.
11. Kawaguchi, H., Kurokawa, T., Hanada, K., Hiyama, Y., Tamura, M., Ogata, E., et al. Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135, 774, 1994.
12. Cowan, C.M., Shi, Y.Y., Aalami, O.O., Chou, Y.F., Mari, C., Thomas, R., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nature Biotechnol 22, 560, 2004.
13. Behr, B., Panetta, N.J., Longaker, M.T., and Quarto, N. Different endogenous threshold levels of fibroblast growth factor-ligands determine the healing potential of frontal and parietal bones. Bone 47, 281, 2010.
14. Quarto, N., Wan, D.C., Kwan, M.D., Panetta, N.J., Li, S., and Longaker, M.T. Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones. J Bone Miner Res 25, 1680, 2010.
15. Behr, B., Tang, C., Germann, G., Longaker, M.T., and Quarto, N. Locally applied VEGFA increases the osteogenic healing capacity of human adipose derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells (Dayton, Ohio) 29, 286, 2011.
16. Brandi, M.L., and Collin-Osdoby, P. Vascular biology and the skeleton. J Bone Miner Res 21, 183, 2006.
17. Kawaguchi, H., Oka, H., Jingushi, S., Izumi, T., Fukunaga, M., Sato, K., et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res 25, 2735, 2010.
18. Behr, B., Sorkin, M., Manu, A., Lehnhardt, M., Longaker, M.T., and Quarto, N. Fgf-18 is required for osteogenesis but not angiogenesis during long bone repair. Tissue Eng 17, 2061, 2011.
19. Lee, J.H., Kim, C.S., Choi, K.H., Jung, U.W., Yun, J.H., Choi, S.H., et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 31, 3512, 2010.
20. Aghaloo, T., Cowan, C.M., Zhang, X., Freymiller, E., Soo, C., Wu, B., et al. The effect of NELL1 and bone morphogenetic protein-2 on calvarial bone regeneration. J Oral Maxillofac Surg 68, 300, 2010.
21. Sawyer, A.A., Song, S.J., Susanto, E., Chuan, P., Lam, C.X., Woodruff, M.A., et al. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 30, 2479, 2009.
22. Cowan, C.M., Aghaloo, T., Chou, Y.F., Walder, B., Zhang, X., Soo, C., et al. MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects. Tissue Eng 13, 501, 2007.
23. Hong, S.J., Kim, C.S., Han, D.K., Cho, I.H., Jung, U.W., Choi, S.H., et al. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects. Biomaterials 27, 3810, 2006.
24. Arnaud, E., De Pollak, C., Meunier, A., Sedel, L., Damien, C., and Petite, H. Osteogenesis with coral is increased by BMP and BMC in a rat cranioplasty. Biomaterials 20, 1909, 1999.
25. Langenfeld, E.M., and Langenfeld, J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2, 141, 2004.
26. Raida, M., Clement, J.H., Leek, R.D., Ameri, K., Bicknell, R., Niederwieser, D., et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131, 741, 2005.
27. Deckers, M.M., van Bezooijen, R.L., van der Horst, G., Hoogendam, J., van Der Bent, C., Papapoulos, S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143, 1545, 2002.
28. Yu, Y.Y., Lieu, S., Lu, C., and Colnot, C. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 47, 65, 2010.
29. Raida, M., Heymann, A.C., Gunther, C., and Niederwieser, D. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 18, 735-9. 2006.
30. Geiger, F., Bertram, H., Berger, I., Lorenz, H., Wall, O., Eckhardt, C., et al. Vascular endothelial growth factor geneactivated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20, 2028, 2005.
31. Kleinheinz, J., Wiesmann, H.P., Stratmann, U., and Joos, U. [Evaluating angiogenesis and osteogenesis modified by vascular endothelial growth factor (VEGF)]. Mund Kiefer Gesichtschir 6, 175, 2002.
32. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
33. Peng, H., Usas, A., Olshanski, A., Ho, A.M., Gearhart, B., Cooper, G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20, 2017, 2005.
34. Li, G., Corsi-Payne, K., Zheng, B., Usas, A., Peng, H., and Huard, J. The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A 15, 2123, 2009.
35. Tokuda, H., Kozawa, O., and Uematsu, T. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. J Bone Miner Res 15, 2371, 2000.
36. Tokuda, H., Hirade, K., Wang, X., Oiso, Y., and Kozawa, O. Involvement of SAPK/JNK in basic fibroblast growth factorinduced vascular endothelial growth factor release in osteoblasts. J Endocrinol 177, 101, 2003.
37. Nakamura, Y., Tensho, K., Nakaya, H., Nawata, M., Okabe, T., and Wakitani, S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 36, 399, 2005.
38. Osyczka, A.M., and Leboy, P.S. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146, 3428, 2005.
39. Jun, J.H., Yoon, W.J., Seo, S.B., Woo, K.M., Kim, G.S., Ryoo, H.M., et al. BMP2-activated Erk/MAP kinase stabilizes Runx2 by increasing p300 levels and histone acetyltransferase activity. J Biol Chem 285, 36410, 2010.
40. Behr, B., Leucht, P., Longaker, M.T., and Quarto, N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Nat Acad Sci USA 107, 11853, 2010.
41. Yu, H., VandeVord, P.J., Mao, L., Matthew, H.W., Wooley, P.H., and Yang, S.Y. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. Biomaterials 30, 508, 2009.
42. Santos, M.I., and Reis, R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10, 12, 2010.
43. Dohle, E., Fuchs, S., Kolbe, M., Hofmann, A., Schmidt, H., and Kirkpatrick, C.J. Sonic hedgehog promotes angiogenesis and osteogenesis in a coculture system consisting of primary osteoblasts and outgrowth endothelial cells. Tissue Eng Part A 16, 1235, 2010.
44. Lawton, M.T., Jacobowitz, R., and Spetzler, R.F. Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 87, 267, 1997.
45. Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C., and Brenner, R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334, 561, 2005.
46. Lind, M., Eriksen, E.F., and Bunger, C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and-6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 18, 53, 1996.
47. Kessler, S., Mayr-Wohlfart, U., Ignatius, A., Puhl, W., Claes, L., and Gunther, K.P. [The impact of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) on osseointegration, degradation and biomechanical properties of a synthetic bone substitute]. Z Orthop Ihre Grenzgeb 141, 472, 2003.